Canadian application, no grantCanada
Use of selective pde5 inhibitors for treating partial and global respiratory failure
CA 2470210 A1 · Owner: Altana Pharma Ag · Inventors: Schudt, Christian; Grimminger, Friedrich Josef; Ghofrani, Ardeschir Hossein
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the novel use of PDE5 inhibitors for the treatment of patients in which a mismatch is present.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 14, 2002
GrantedNo grant recorded
Term endedDecember 14, 2022
Patent numberCA 2470210 A1
Classification (IPC)A61K31/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.